Outbreaks, persistence, and high mortality rates of multiresistant Pseudomonas aeruginosa infections in a hospital with AIDS-predominant admissions
Tóm tắt
Từ khóa
Tài liệu tham khảo
Deplano, 2005, Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa, J Clin Microbiol, 43, 1198, 10.1128/JCM.43.3.1198-1204.2005
Yakupogullari, 2008, Investigation of a nosocomial outbreak by alginate-producing pan-antibioticresistant Pseudomonas aeruginosa, Am J Infect Control, 36, e13, 10.1016/j.ajic.2008.07.006
Adachi, 2009, The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients, Am J Infect Control, 37, 442, 10.1016/j.ajic.2008.09.012
Hota, 2009, Outbreak of multidrug-resistant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design, Infect Control Hosp Epidemiol, 30, 25, 10.1086/592700
Cortes, 2009, Identifying and controlling a multiresistant Pseudomonas aeruginosa outbreak in a Latin-American cancer centre and its associated risk factors, Braz J Infect Dis, 13, 99, 10.1590/S1413-86702009000200005
Cezário, 2009, Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital, Enferm Infecc Microbiol Clin, 27, 269, 10.1016/j.eimc.2008.09.009
Samuelsen, 2010, Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion, Antimicrob Agents Chemother, 54, 346, 10.1128/AAC.00824-09
Zavascki, 2010, Multidrugresistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy, Expert Rev Anti Infect Ther, 8, 71, 10.1586/eri.09.108
Domingo, 1998, Pseudomonas aeruginosa bronchopulmonary infection in patients with AIDS, with emphasis on relapsing infection, Eur Respir J, 12, 107, 10.1183/09031936.98.12010107
Asboe, 1998, Persistence of Pseudomonas aeruginosa strains in respiratory infection in AIDS patients, AIDS, 12, 1771, 10.1097/00002030-199814000-00008
Johnson, 2007, Multilocus sequence typing compared to pulsed-field gel electrophoresis for molecular typing of Pseudomonas aeruginosa, J Clin Microbiol, 45, 3707, 10.1128/JCM.00560-07
Pereira, 2008, Controlling the clonal spread of Pseudomonas aeruginosa infection, Infect Control Hosp Epidemiol, 29, 549, 10.1086/588163
Garner, 1988, CDC definitions for nosocomial infections, Am J Infect Control, 16, 128, 10.1016/0196-6553(88)90053-3
Emori, 1991, National Nosocomial Infections Surveillance system (NNIS): description of surveillance methods, Am J Infect Control, 19, 19, 10.1016/0196-6553(91)90157-8
Horan, 2008, CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting, Am J Infect Control, 36, 309, 10.1016/j.ajic.2008.03.002
Laing, 1999, Nosocomial infections in patients with HIV disease, J Hosp Infect, 43, 179, 10.1053/jhin.1999.0617
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 18th informational supplement. M100-S17. Wayne, PA: NCCLS, 2007.
Arakawa, 2000, Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds, J Clin Microbiol, 38, 40, 10.1128/JCM.38.1.40-43.2000
Romão, 2005, Susceptibility of clinical isolates of multiresistant Pseudomonas aeruginosa to a hospital disinfectant and molecular typing, Mem Inst Oswaldo Cruz, 100, 541, 10.1590/S0074-02762005000500015
Tenover, 1995, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing, J Clin Microbiol, 33, 2233, 10.1128/JCM.33.9.2233-2239.1995
Furtado, 2006, Clinical culture surveillance of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter species in a teaching hospital in Sao Paulo, Brazil: a 7-year study. Infect Control Hosp Epidemiol, 27, 1270
Thuong, 2003, Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit, J Hosp Infect, 53, 274, 10.1053/jhin.2002.1370
Lepelletier, 2010, Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms, Diagn. Microbiol. Infect. Dis, 66, 1, 10.1016/j.diagmicrobio.2009.08.014
Slekovec, 2010, Is surveillance of Pseudomonas aeruginosa carriage in intensive care units useful?, Ann Fr Anesth Reanim, 29, 279, 10.1016/j.annfar.2009.12.023
Bertrand, 2001, Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units, Intensive Care Med, 27, 1263, 10.1007/s001340100979
Fortaleza, 2009, Risk factors of oropharyngeal carriage of Pseudomonas aeruginosa among patients from a Medical-Surgical Intensive Care Unit, Braz J Infect Dis, 13, 173, 10.1590/S1413-86702009000300004
Panagea, 2005, Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces, J Hosp Infect, 59, 102, 10.1016/j.jhin.2004.09.018
Clifton, 2008, A laminar flow model of aerosol survival of epidemic and non-epidemic strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis, BMC Microbiol, 8, 105, 10.1186/1471-2180-8-105
Nunes, 2005, Indoor air microbiological evaluation of offices, hospitals, industries, and shopping centers, Mem Inst Oswaldo Cruz, 100, 351, 10.1590/S0074-02762005000400003
Pagani, 2005, Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta-lactamase, J Clin Microbiol, 43, 3824, 10.1128/JCM.43.8.3824-3828.2005
Jonas, 2008, Genodiversity of resistant Pseudomonas aeruginosa isolates in relation to antimicrobial usage density and resistance rates in intensive care units, Infect Control Hosp Epidemiol, 29, 350, 10.1086/528811
Quale, 2006, Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates, Antimicrob Agents Chemother, 50, 1633, 10.1128/AAC.50.5.1633-1641.2006
Pai, 2001, Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates, Antimicrob Agents Chemother, 45, 480, 10.1128/AAC.45.2.480-484.2001
Lodise, 2007, Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance, Antimicrob Agents Chemother, 51, 417, 10.1128/AAC.00851-06
Bhat, 2007, Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms, Antimicrob Agents Chemother, 51, 4390, 10.1128/AAC.01487-06
Crandon, 2010, Clinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa, Antimicrob Agents Chemother, 54, 1111, 10.1128/AAC.01183-09
Deal, 2009, Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, openlabel, prospective, observational study, Clin Ther, 31, 299, 10.1016/j.clinthera.2009.02.015
Davies, 2002, Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence, Paediatr Respir Rev, 3, 128, 10.1016/S1526-0550(02)00003-3
Ferreira, 2010, Influence of biofilm formation in the susceptibility of Pseudomonas aeruginosa from Brazilian patients with cystic fibrosis, APMIS, 118, 606, 10.1111/j.1600-0463.2010.02636.x
Murphy, 2004, Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection, Emerg Infect. Dis, 10, 109, 10.3201/eid1001.020714
Zavascki, 2006, Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals, J. Antimicrob. Chemother, 58, 882, 10.1093/jac/dkl327